Objectives To examine if therapeutic hypothermia reduces the composite outcome of death,
moderate or severe disability at 18 months or more after mild neonatal encephalopathy …

There is increasing evidence that infants with mild neonatal encephalopathy (NE) have
significant risks of mortality, brain injury and adverse neurodevelopmental outcomes. In the …

Objectives: Identify the physiological criteria used for calculating the Apgar score. Describe
the clinical relevance of the Apgar score. Outline the limitations of the Apgar score. Explain …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Background Mild hypoxic-ischemic encephalopathy (HIE) is increasingly recognized as a
risk factor for neonatal brain injury. We examined the timing and pattern of brain injury in …

Introduction: Hypoxic-ischemic encephalopathy (HIE) is a crucial cause of neonatal death
and neurological sequelae, but currently there is no effective therapy drug for HIE. Both …

OBJECTIVES: To develop predictive models for death or neurodevelopmental impairment
(NDI) after neonatal hypoxic-ischemic encephalopathy (HIE) from data readily available at …

Neonates with neonatal encephalopathy (NE) often present with multi-organ dysfunction that
requires multidisciplinary specialized management. Care of the neonate with NE is thus …

Objective This study was aimed to describe utilization of therapeutic hypothermia (TH) in
neonates presenting with mild hypoxic-ischemic encephalopathy (HIE) and associated …

The antioxidant defense system is involved in the pathogenesis of neonatal hypoxic-
ischemic encephalopathy (HIE). To analyze the relationship between first serum blood …